COVID-19 Treatment Clinics

These clinics have been launched to help our patients access outpatient therapies such as monoclonal antibody treatment when available.

The Inova Extended COVID-19 Care Clinics are accepting referrals for patients from all Inova Emergency Rooms, Inova Urgent Care Centers, Inova Primary Care Offices, as well as community practices.

Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful antigens such as viruses. The monoclonal antibody treatments offered specifically target the spike protein.

Monoclonal antibodies can be delivered by both infusion or by subcutaneous injection. 

We continue to have very limited supply of infusion drugs and do not have enough stock to offer treatment to everyone that meets EUA criteria. NOTE: If the patient has been prescribed and can obtain oral COVID-19 treatment, the patient will not be considered eligible for a mAb infusion.

Effective Jan. 20, 2022, we will expanding to Tier 2 inclusion criteria for all mAb infusions. To qualify for consideration, patients need a positive COVID-19 test and must be within 7 days of illness onset and also meet at least one of the criteria below:

1. Moderate to severe Immunocompromised OR
2. One of the following:

• Age < 5 y.o. with at least one additional risk factor for severe disease
• BMI ≥35 (or > 85th percentile if < 18 years old).
• Age ≥65
• Pregnancy
• Chronic kidney disease
• Diabetes
• Cardiovascular disease (not hypertension)
• Chronic lung diseases (for example, chronic obstructive pulmonary disease, asthma [moderate-to-severe], interstitial lung disease, cystic fibrosis and pulmonary hypertension)
• Sickle cell disease
• Neurodevelopmental disorders (for example, cerebral palsy) or other conditions that confer medical complexity (for example, genetic or metabolic syndromes and severe congenital anomalies)
• Having a medical-related technological dependence [for example, tracheostomy, gastrostomy, or positive pressure ventilation (not related to COVID- 19)

As a result of a very high case load as well as significantly restricted supply, we are currently managing ALL Monoclonal Antibody requests online. We have also instituted restricted eligibility for treatment at our infusion centers and emergency rooms. Please submit all requests for treatment using the link(s) below. Note that you or your patient will ONLY receive a call to schedule a treatment if: 1) the patient meets the majority of criteria; and 2) we have supply available.

Providers:

Complete this form to refer a symptomatic patient.

Patients (symptomatic only):

To be referred, please contact your primary care provider. If you do not have a primary care provider, complete the online self-referral form. If you meet the revised criteria and we have the drug available, you will receive a call to be scheduled for a telemedicine appointment with an Inova Primary Care Provider to see if you qualify for the monoclonal infusion treatment.

The monoclonal antibody treatment is currently available by the FDA through Emergency Use Authorization (EUA).

An Emergency Use Authorization (EUA) is a mechanism to facilitate the availability and use of medical countermeasures, including vaccines, during public health emergencies, such as the current COVID-19 pandemic.

The COVID-19 treatment has been proven to reduce hospital admissions. The most common side effect shown in studies has been nausea. This medication has been very well tolerated. Nevertheless, Inova providers will be closely monitoring you for 1 hour after treatment to ensure your safety.

There have not been any studies on pregnant patients. Given the low risk associated with this medication, pregnant patients can receive the treatment if requested.

The cost of any telemedicine visits or infusion fee are covered by Medicare, Medicaid, and commercial insurance. Co-pays may apply. The infusion and telemedicine visits are available to the uninsured who can apply for financial assistance.

Inova is not charging for the COVID-19 treatment, but will charge for administering the medication. Charges will vary depending on your coverage.

Uninsured patients can apply for financial assistance. Financial assistance coverage will depend on qualifications.